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Objective: Some studies have suggested alterations of structural brain asymmetry in attention-deficit/hyperactivity
disorder (ADHD), but findings have been contradictory and based on small samples. Here, we performed the largest
ever analysis of brain left-right asymmetry in ADHD, using 39 datasets of the ENIGMA consortium. Methods: We
analyzed asymmetry of subcortical and cerebral cortical structures in up to 1,933 people with ADHD and 1,829
unaffected controls. Asymmetry Indexes (AIs) were calculated per participant for each bilaterally paired measure, and
linear mixed effects modeling was applied separately in children, adolescents, adults, and the total sample, to test
exhaustively for potential associations of ADHD with structural brain asymmetries. Results: There was no evidence
for altered caudate nucleus asymmetry in ADHD, in contrast to prior literature. In children, there was less rightward
asymmetry of the total hemispheric surface area compared to controls (t = 2.1, p = .04). Lower rightward asymmetry
of medial orbitofrontal cortex surface area in ADHD (t = 2.7, p = .01) was similar to a recent finding for autism
spectrum disorder. There were also some differences in cortical thickness asymmetry across age groups. In adults
with ADHD, globus pallidus asymmetry was altered compared to those without ADHD. However, all effects were small
(Cohen’s d from −0.18 to 0.18) and would not survive study-wide correction for multiple testing. Conclusion: Prior
studies of altered structural brain asymmetry in ADHD were likely underpowered to detect the small effects reported
here. Altered structural asymmetry is unlikely to provide a useful biomarker for ADHD, but may provide
neurobiological insights into the trait. Keywords: Attention-deficit; hyperactivity disorder; brain asymmetry; brain
laterality; structural MRI; large-scale data.
Introduction
Attention-deficit/hyperactivity disorder (ADHD) is
among the most frequently diagnosed childhood-
onset mental disorders, affecting 5% of individuals
worldwide (Polanczyk, de Lima, Horta, Biederman, &
Rohde, 2007). ADHD is characterized by develop-
mentally inappropriate and impairing levels of inat-
tention and/or hyperactivity, impulsivity, and
emotional dysregulation (American Psychiatric Asso-
ciation, 2013). At least 15% of children diagnosed
with ADHD retain the diagnosis into adulthood
(Faraone et al., 2015; Fayyad et al., 2017).
Left-right asymmetry (laterality) is an important
feature of human brain organization (Duboc,
Dufourcq, Blader, & Roussigne, 2015; Renteria,
2012; Toga & Thompson, 2003), and altered struc-
tural or functional asymmetry has been reported for
a range of psychiatric conditions (Toga & Thompson,
2003). The right hemisphere is typically dominant
for some aspects of attention and arousal (Heilman,
Bowers, Valenstein, & Watson, 1986), and it was
observed in the 1980s that people with unilateral
lesions in the right hemisphere can show ADHD-like
symptoms (Heilman et al., 1986). Since then, various
neuropsychological and functional imaging studies
have found differences between people with ADHD
compared to controls (e.g., (Cortese et al., 2012)),
with some pointing to a particular involvement of
right hemisphere alterations (Geeraerts, Lafosse,
Vaes, Vandenbussche, & Verfaillie, 2008; Hale
et al.,2010, 2014; Langleben et al., 2001; Stefanatos
& Wasserstein, 2001; Vance et al., 2007). However,
not all functional data fit a primarily right-hemi-
sphere model (Hale et al., 2009; Mohamed, Börger,
Geuze, & van der Meere, 2016; Zou & Yang, 2019).
In terms of brain anatomy, several studies have
reported altered asymmetry of the caudate nucleus
in ADHD, although not consistently in the direction
of effect (Castellanos et al., 1996; Dang et al., 2016;
Filipek et al., 1997; Hynd et al., 1993; Schrimsher,
Billingsley, Jackson, & Moore, 2002; Uhlikova et al.,
2007). Altered asymmetry of gray matter volumes in
the superior frontal and middle frontal gyri has been
reported in ADHD (Cao et al., 2014), as well as
decreased asymmetry of cortical convolution com-
plexity in the prefrontal cortex (X. Li et al., 2007).
Reduced hemispheric asymmetry of white matter
networks has also been reported in ADHD compared
Conflict of interest statement: See Acknowledgements for full
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to controls (D. Li et al., 2018). Douglas et al. (Dou-
glas et al., 2018) performed the largest study of brain
anatomical asymmetry in ADHD to date, including
192 cases with ADHD with a history of pharma-
cotherapy, 149 medication-naı̈ve cases with ADHD,
and 508 typically developing controls (ages 6–-
21 years), from eight separate datasets. They calcu-
lated per-subject Asymmetry Indexes (AI) for various
regional gray matter volumes, AI = (Left-Right)/
((Left + Right)/2) (a widely used approach in studies
of brain asymmetry (Kong et al., 2018; Kurth, Gaser,
& Luders, 2015; Leroy et al., 2015; Postema et al.,
2019)), but did not find any significant alterations of
AIs in ADHD (Douglas et al., 2018). However, in a
subset of their dataset (56 cases and 48 controls),
Douglas et al. (Douglas et al., 2018) analyzed diffu-
sion tensor imaging (DTI) data, including fractional
anisotropy and mean diffusivity measures, and
reported alterations in the asymmetry of six white
matter tracts, again not specifically driven by alter-
ations in the right hemisphere.
In the current study, we measured cortical regional
AIs in 1,978 cases and 1,917 controls from 39
datasets, and subcortical AIs in 1,736 cases and
1,654 controls from 35 datasets, made available via
the ADHD working group of the ENIGMA (Enhancing
NeuroImaging Genetics through MetaAnalysis) con-
sortium. The same datasets were recently analyzed in
two other studies, by Hoogman et al.(Hoogman et al.,
2017, 2019), that investigated bilateral changes in
subcortical volumes and cortical measures, but not
alterations of asymmetry. They found that ADHDwas
associated with lower average volumes of various
subcortical structures (Hoogman et al., 2017), as well
as lower total and regional cortical surface areas
(including frontal, cingulate, and temporal regions),
and decreased cortical thickness in fusiform gyrus
and temporal pole (Hoogman et al., 2019). These
effects were largest in children, and even child-
specific for the cortical findings, so that for the
present study of asymmetries, we followed the age-
group division of Hoogman et al. (Hoogman et al.,
2019) into children (<15 years), adolescents (15–-
21 years), and adults (>21 years), as well as per-
forming analysis in the total combined sample to
explore age-general effects. Bilateral effect sizes
reported by Hoogman et al. (Hoogman et al., 2017,
2019) were small, that is, case–control Cohen’s d
values between −.21 and .06. This suggests that, if
associations between ADHD diagnosis and regional
brain asymmetries are similarly subtle, many previ-
ous studies of anatomical asymmetries in this disor-
der were underpowered, and the described effects
may have been unreliable. Low statistical power in a
study not only reduces the chance of detecting true
effects, but also the likelihood that significant results
reflect true effects (Munafo & Flint, 2010). It is
important for the field of neuroimaging to mature
around more highly powered analyses in relation to
subtle effects. The current study aimed to provide
detailed information on the extent to which laterality
is affected in ADHD, based on the largest ever sample
size for this question, comprised of multiple inde-
pendent cohorts from around the world.
Methods
Ethical considerations
This study made use of 39 pre-existing datasets from around
the world. For all datasets, the participating sites had obtained
ethical approval from local institutional review boards, as well
as informed consent to participate.
Datasets
Bilateral brain measures derived from structural MRI were
available from 39 different datasets via the ENIGMA-ADHD
Working Group (Table S1). The 39 datasets comprised cortical
data froma total of 1,933 participants with ADHD (1,392males;
median age = 15 y; range = 4 y to 62 y) and 1,829 healthy
individuals (1,116 males; median age = 14 y; range = 4 y to
63 y). Subcortical data were available from 35 of the 39 datasets
and comprised 1,691 cases (1,212 males, median age = 15 y;
range = 5 y to 62 y) and 1,566 controls (953 males, median
age = 14y;range = 4yto63y).ApreviousstudybyDouglasetal.
(Douglas et al., 2018) (see Introduction) included five datasets
that were also analyzed in the present study (Table S1).
For all but 4 of the 39 datasets, ADHD diagnosis was based
on the Diagnostic and Statistical Manual of Mental Disorders
4th Edition (DSM-IV) (American Psychiatric Association, 2000).
Other instruments used were DSM5th Edition (DSM-5), or the
International Classification of Diseases (ICD)10th Edition)
(World Health Organization, 1992). For information per dataset
see, Table S1.
In terms of age groups, for children (<15 y) there were
subcortical data from 802 cases and 842 controls, and cortical
data from 912 cases and 950 controls; for adolescents (15 y–21
y) there were subcortical data from 326 cases and 232
controls, and cortical data from 408 cases and 340 controls;
for adults (> 21 years) there were subcortical data from 563
cases and 492 controls, and cortical data from 613 cases and
539 controls.
Eleven additional datasets, comprising cases-only or con-
trols-only, were excluded for the purpose of the present study
(these are not listed in Table S1). This was because our
analysis models included random intercepts for ‘dataset’
(below), and diagnosis would be fully confounded with ‘dataset’
for case-only or control-only datasets.
MRI-based measures
Structural T1-weighted brain MRI scans had been acquired at
each study site for each of the 39 pre-existing MRI datasets.
MRI data within the ENIGMA consortium are typically pro-
cessed separately at each participating site, due to varying
restrictions on data sharing that apply to the many legacy
datasets from different countries around the world. Images
were obtained at different field strengths (1.5 T or 3 T: see
Table S1). Scanners and scanning sequences, recruitment
criteria, and demographics differed between datasets, but all
sites separately applied a single image processing and quality
control protocol from the ENIGMA consortium (http://enigma.
ini.usc.edu/protocols/imaging-protocols), starting from their
T1 image data. The harmonized processing was based on the
freely available and validated software FreeSurfer (versions 5.1
or 5.3) (Fischl, 2012), with the default ‘recon-all’ pipeline
(https://surfer.nmr.mgh.harvard.edu/fswiki/recon-all), which
is a 29-step procedure that includes skull stripping,
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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registration, subcortical segmentation, normalization, white
matter and pial surface creation, cortical parcellation according
to the Desikan-Killiany atlas, and the output of region-specific
measures of volume, average thickness, and surface area. This
was followed by visual inspection of both internal and external
segmentations (Supplementary Methods). Exclusions on the
basis of these quality control steps resulted in the sample sizes
given above. The present study took as its starting point the
FreeSurfer-derived measures of left and right volumes of seven
bilaterally paired subcortical structures, and thickness and
surface area measures for each of 34 bilaterally paired cortical
regions, that were generated previously by each site. The
cortical regions were defined by the Desikan-Killiany atlas
(Desikan et al., 2006). In addition, the average cortical thickness
and total surface area per hemisphere were analyzed. Free-
Surfer’s measure of intracranial volume (ICV) was also consid-
ered as a covariate in sensitivity analyses (below).
The Desikan-Killiany atlas (Desikan et al., 2006) was
derived from manual segmentations of reference brain
images. The labeling system incorporates hemisphere-specific
information on sulcal and gyral geometry with spatial infor-
mation regarding the locations of brain structures (Desikan
et al., 2006). Accordingly, the mean regional asymmetries in
our data might be influenced by left-right differences present
in the reference dataset used for constructing the atlas.
Nonetheless, this approach was appropriate for our study
focused on comparing relative asymmetry between groups.
The use of an asymmetrical atlas has the advantage that
regional identification is likely to be accurate for structures
that are asymmetrical both in the atlas and, on average, in
the study population.
Asymmetry indexes
Left and right data per brain region and individual participant
were loaded into R (version 3.5.3), and null values were
removed. An asymmetry index (AI) was calculated for each
subject and each paired left-right measure using the following
formula: (Left-Right)/(Left + Right). Negative AIs therefore
indicate a right > left asymmetry, while positive AIs indicate
a left > right asymmetry. In the AI formula, the L-R difference
(numerator) is adjusted by the bilateral measure L + R (de-
nominator), such that the AI does not scale with the bilateral
measure. We did not divide the denominator by 2, in contrast
to some previous formulations of AIs (see Introduction), but
this makes no difference in terms of deriving Cohen’s d effect
sizes and p-values for group comparisons. Distributions of
each of the AIs in the total study sample are plotted in
Figure S1.
Correlations between AI measures in the total study sample
were calculated using Pearson’s R and visualized using the
corrplot package in R (Figures S2–S4). Most pairwise correla-
tions between AIs were of low magnitude (median magnitude
r = .024 for surface area AIs, 0.040 for thickness AIs, 0.091 for
subcortical volume AIs), with a minimum r = −.42 between
caudal anterior cingulate surface area and superior frontal
surface area, and maximum r = .49 between rostral middle
frontal thickness and total average thickness.
Linear mixed effects random-intercept models
Main analysis. Linear mixed effects analyses were per-
formed separately for each subcortical volume AI, cortical
regional surface and thickness AI, and the total hemispheric
surface area, and average thickness AI, using the nlme
package in R (version 3.5.3). Analyses were conducted sepa-
rately within children, adolescents, and adults, as well as on
the total study sample. All models included diagnosis (a binary
variable; 0 = control, 1 = case), sex (binary; 0 = female, 1 =
male), and age (numeric) as fixed factors, and dataset as a
random factor (39 categories for cortical data, 35 categories for
subcortical data):
AI diagnosisþsexþageþ random 1jdatasetð Þ (1)
The maximum likelihood (ML) method was used to fit the
models. Whenever any of the predictor variables was missing
in a given subject, the subject was omitted from the analysis
(method = ‘na.omit’). The ‘optim’ optimizer (lmeControl(opt=‘-
optim’) was used for all models. Residual plots are in Fig-
ures S5–S7.
The t-statistic for the factor ‘diagnosis’ in each linear mixed
effects model was derived and used to calculate Cohen’s d
(Supplementary Methods). For visualization of cerebral cortical
results, Cohen’s d values were loaded into Matlab (v. R2020a)
and 3D images of left hemisphere inflated cortical and
subcortical structures were obtained using FreeSurfer-derived
ply files.
Field strength was not included as a covariate because each
dataset was scanned entirely at either 1.5 T or 3T (Table S1),
and the models included ‘dataset’ as a random-intercept effect,
which adjusted for differences that applied to entire datasets.
Significance and detectable effect sizes. Signifi-
cance was assessed based on the p-value for the diagnosis
term within each model. Separately within each age group, and
again within all age groups combined, we applied false
discovery rate (FDR) correction (Benjamini & Hochberg,
1995) for multiple testing, separately across the seven sub-
cortical structures, the 35 cortical surface area AIs (i.e., 34
regional AIs and one hemispheric total AI), and again for the 35
cortical thickness AIs, each time with an FDR threshold of
0.05. Therefore, twelve separate FDR corrections were done.
We also applied an additional FDR correction for the total
combined analysis across all age groups and AIs of different
types.
As each linear model included multiple predictor variables,
the power to detect an effect of diagnosis on AI could not be
computed exactly, but we obtained an indication of the effect
size that would be needed to provide 80% power had we been
using simple t-tests and Bonferroni correction for multiple
testing, using the pwr command in R (Supplementary Meth-
ods). For this purpose, a significance level of 0.0071 (i.e., 0.05/
7) or 0.0014 (i.e., 0.05/35) was set in the context of multiple
testing over the seven subcortical volumes, or the regional and
total cortical surface areas (N = 35) or thicknesses (N = 35).
This showed that, in the total study sample, a case–control
effect size of roughly Cohen’s d = .12 (subcortical), or d = .13
(cortical), would be detectable with 80% power. For the
analyses in the different age groups, this was, respectively,
d = .16 and d = .19 in children, d = .26 and d = .30 in
adolescents, and d = .21 and d = .24 in adults.
Directions of asymmetry changes. For any AIs show-
ing nominally significant effects (i.e., unadjusted p < .05) of
diagnosis in any of the primary analyses, post hoc linear mixed
effects modeling was also performed on the corresponding L
and R measures separately, to understand the unilateral
changes involved. The models included the same terms as
were used in the main analysis of AIs (i.e., diagnosis, age and
sex as fixed factors, and dataset as random factor). Again, the
Cohen’s d effect sizes for diagnosis were calculated based on
the t-statistics. The raw mean AI values were calculated
separately in controls and cases, to describe the reference
direction of healthy asymmetry in controls, and whether cases
showed lower, higher, or reversed asymmetry relative to
controls.
Sensitivity analyses. The relationships between AIs and
age appeared roughly linear across all age groups combined
(Figures S8–S10). Therefore, no polynomials for age were
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incorporated in the main model (Supplementary Methods).
However, analyses were repeated (only for all age groups
combined) using an additional nonlinear term for age, to check
whether this choice had affected the results. The variables age
and age2 are inevitably highly correlated. To include linear and
nonlinear effects of age in the same model, we made use of the
poly()-function in R for these two predictors, which created a
pair of uncorrelated variables related to age (so-called orthog-
onal polynomials) (Chambers & Hastie, 1992), where one
variable was linear and one nonlinear:
AI diagnosisþpoly age,2ð Þþsexþ random 1jdatasetð Þ (2)
Note that we were not interested to measure the effects of age
or age-squared, but simply to correct for linear and nonlinear
effects related to age, as we measured the effects of diagnosis
on brain asymmetry.
No AI outliers were removed for the main analysis, but to
confirm that results were not dependent on outliers, the main
analysis was also repeated (for all age groups combined) after
having winsorized using a threshold of k = 3, for each AI
measure separately in the total combined dataset.
Associations between brain asymmetries and IQ,
comorbidity, ADHD severity, and psychostimulant
medication. Within the ADHD participants only (all age
groups combined), brain asymmetries were tested in relation to
several potentially associated variables (IQ, comorbidity, sever-
ity, medication use; see Figures S11 and S12), using separate
models in which each variable was considered as a fixed effect:
AI variableþageþsexþ random 1jdatasetð Þ (3)
See Supplementary Methods for the derivation of these
variables. For binary variables, datasets were removed if they
had < 1 subject per category, to avoid the random variable
‘dataset’ being fully confounded with the binary variable for
any datasets. Depending on the availability of each specific AI,
data for testing association with IQ were available for up to
1,719 ADHD individuals (exact numbers per AI depended on
image quality control for that region and can be found in the
relevant results tables, see below). For the presence/absence
of comorbidities, four different binary variables were con-
structed: mood disorder (up to 179 yes, 384 no), anxiety
disorder (up to 82 yes, 503 no), oppositional defiant disorder
(ODD; up to 80 yes, 151 no), and substance use disorder (SUD;
up to 77 yes, 335 no). For ADHD symptom severity, two
continuous variables were used: hyperactivity/impulsivity (up
to 1,009 ADHD participants) and inattention (1,006 ADHD
participants). For psychostimulant medication use, two binary
variables were constructed: lifetime use (up to 337 yes, 188
no), and current use (i.e., at the time of scanning, up to 361
yes, 377 no) (see Figures S12 for the distributions, and
Supplementary Methods for more explanation).
IQ was also examined in controls-only (all age groups
combined) to explore the relationships between IQ and brain
asymmetries in typically developing individuals. IQ and AI data
were available for up to 1,663 controls. The model for each AI
was:
AI IQþageþsexþ random 1jdatasetð Þ:
IQ, handedness, and intracranial volume as
covariates in disorder case–control analysis. See
the Supporting Information for the derivation of IQ and
handedness measures, and above for ICV. Distributions are
in Figures S11. We did not adjust for IQ, handedness, or ICV
as covariate effects in our main, case–control analysis (above).
This was because, a priori, there are various possible causal
relations linking these traits to ADHD and brain asymmetry
and other, possibly underlying factors shared between some or
all of them. In this context, it is important not to bias
associations between ADHD and brain asymmetry through
correcting for these factors as covariates in primary analysis,
as they may be colliders (Cole et al., 2010) (see the Discussion
for more on this issue). However, we included a set of
additional, secondary models to test for case–control effects
in the presence of these variables as covariates:
AI ~ diagnosis + age + sex + + handedness + random (~1 |
dataset)
AI ~ diagnosis + age + sex + handedness + handedness*di-
agnosis + random (~1 | dataset)
AI ~ diagnosis + age + sex + IQ + random (~1 | dataset)
AI ~ diagnosis + age + sex + IQ + IQ*diagnosis + random
(~1 | dataset)
AI ~ diagnosis + age + sex + + ICV + random (~1 | dataset)
AI ~ diagnosis + age + sex + ICV + ICV*diagnosis + random
(~1 | dataset)
The analyses were also repeated after winsorization of
outliers, as above.
Results
Associations of brain asymmetry with ADHD
Results for all AIs across the different age groups,
and for all age groups combined, are listed in the
supplement (Tables S2–S13), and are also available
as supplementary comma-delimited text files.
Children. There were no associations of diagnosis
with AIs that had FDR < 0.05 in children
(Tables 1–3, Tables S2–S4). The children showed
nominally significant associations (unadjusted
p < .05) of diagnosis with the AIs of total hemi-
spheric surface area (t = 2.10, p = .036), medial
orbitofrontal cortex surface area (t = 2.7, p = .006),
and paracentral lobule surface area (t = −2.16,
p = .031) (Table 1, Table S3). The Cohen’s d for
these effects were .11, .13 and −.10, respectively
(Figure 1, Figures S13, Table S3). Post hoc analysis
showed that the effects on total hemispheric and
medial orbitofrontal surface area asymmetries both
involved relatively greater reductions on the right-
side than left-side in ADHD compared to controls
(Table S14). The effect on paracentral lobule surface
area asymmetry was driven by a larger decrease of
left compared to right-hemispheric surface area in
this region (Table S14).
The children also showed nominally significant
associations of diagnosis with four regional cortical
thickness AIs, which were the banks of the superior
temporal sulcus (t = −2.0, p = .047; increased right-
ward asymmetry in ADHD), caudal middle frontal
cortex (t = 2.1, p = .037; increased leftward asym-
metry), precentral gyrus (t = 2.4, p = .019; increased
leftward asymmetry) and insula (t = −2.0, p = .047,
decreased leftward asymmetry) (Table 2, Table S14).
Adolescents. There were two nominally significant
associations between diagnosis and AIs in
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adolescents, but none with FDR < 0.05 (Tables 1–3,
Tables S5–S7). These involved the pars orbitalis of
inferior frontal gyrus surface area (t = 2.4, p = .017),
which showed lower rightward asymmetry in ADHD
compared to controls, due to a smaller left than
right-sided decrease (Table S14), and cuneus thick-
ness (t = −2.0, p = .043), which showed greater
rightward asymmetry in ADHD compared to con-
trols, due to an increase in right- and a decrease in
left-hemispheric thickness (Table S14).
Adults. In adults, the globus pallidus AI was
significantly associated with ADHD diagnosis with
FDR < 0.05 (t = −2.9, p = .004, uncorrected)
(Table 1, Table S8). The Cohen’s d effect size for this
association was −.18 (Table 1, Figure 1, Figure S13).
This effect involved a decrease in leftward asymmetry
in ADHD compared to controls, driven by a larger
reduction of left-side volume than right-side volume
in ADHD compared to controls (Table S14). Note this
association was only significant in the context of
FDR correction for 7 subcortical AIs within adults
specifically. (No effects were significant at FDR-
corrected p < .05 when the correction was done
across all age groups and AIs of different types, see
below).
There were other nominally significant associa-
tions of AIs with diagnosis in adults: lateral occipital
cortex surface area (t = 2.0, p = .049; increased
leftward) (Table 2, Tables S9 and S14) and thickness
(t = 2.2, p = .026; decreased rightward) (Table 3,
Tables S10 and S14), medial orbitofrontal cortex
thickness (t = 2.0, p = .045; increased leftward),
middle temporal gyrus thickness (t = −2.6,
p = .009; increased rightward), pericalcarine cortex
thickness (t = 2.9, p = .004; decreased rightward),
and postcentral gyrus thickness (t = −2.5, p = .013;
decreased leftward). The corresponding unilateral
effects are shown in Table S14.
All age groups combined. When combining all age
groups, there were nominally significant associa-
tions of AIs with diagnosis for the medial
orbitofrontal cortex surface area (t = 2.2, p = .029;
decreased rightward), paracentral lobule surface
area (t = −2.2, p = .029; increased rightward), pars
orbitalis of inferior frontal gyrus surface area
(t = 2.3, p = .021; decreased rightward), caudal mid-
dle frontal thickness (t = 2.2, p = .027; increased
leftward), insula thickness (t = −2.1, p = .040;
decreased leftward), as well as the volume of the
globus pallidus (t = −2.6, p = .010; decreased left-
ward) (Tables 1–3, Tables S11–S13). The corre-
sponding unilateral effects are shown in Table S14.
No effects were significant at FDR-corrected
p < .05 when the correction was done across all
age groups and AIs of different types.
The addition of nonlinear effects of age to the
model had negligible influences on the six nominally
significant associations with diagnosis, all of which
remained nominally significant except insula thick-
ness (now p = .050). Likewise, winsorizing outliers
(using a threshold k = 3, see Methods) also had little
influence on the results (the effect on insula thick-
ness asymmetry was no longer nominally significant,
p = .061) (Tables S15–S17).
Associations brain asymmetries with comorbidity,
ADHD severity, psychostimulant medication, and IQ
Analyses in this section were carried out in all age
groups combined.
When testing associations of comorbidity, ADHD
severity, psychostimulant medication, or IQ with
brain asymmetries within ADHD individuals
(Tables S18–S29), only one significant association
was found (FDR < 0.05 within the particular type of
AI and age-defined group), namely between comor-
bid mood disorder and the rostral middle frontal
gyrus thickness AI (p = .0002, t = 3.70) (Table S26).
Furthermore, various nominally significant (p < .05)
associations were observed: ADHD severity was
associated with the AI of the entorhinal cortex
surface area (t = 2.12, p = .034; hyperactivity/im-
pulsivity) (Table S19). ADHD severity was also asso-
ciated with four regional cortical thickness
Table 1 Linear mixed model results for subcortical volume AIs
Subcortical volume AI
Children only Adolescents only Adults only
Total study
sample
pa db pa db pa db pa db
Accumbens .26 −.06 .36 −.08 .90 .01 .32 −.03
Amygdala .78 −.01 .72 .03 .69 −.03 .61 −.02
Caudate Nucleus .60 .03 .88 .01 .45 .05 .41 .03
Globus Pallidus .65 −.02 .39 −.08 .004 −.18 .01 −.09
Hippocampus .84 −.01 .09 .15 .46 .05 .62 .02
Putamen .54 −.03 .87 −.02 .52 −.04 .26 −.04
Thalamus .42 .04 .28 .10 .48 .04 .15 .05
aUncorrected p-values for diagnosis are indicated, with in bold those that are significant at the uncorrected level (p < 0.05), and in
bold-italic those that survive multiple testing correction within the particular analysis indicated (see text).
bCohen’s d value for the effect of diagnosis.
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asymmetries: the caudal anterior cingulate thick-
ness AI (t = 2.66, p = .008; hyperactivity/impulsiv-
ity), pars opercularis of the inferior frontal gyrus
thickness AI (t = 2.12, p = .034; hyperactivity/im-
pulsivity, and t = 2.04, p = .04; inattention), and
pericalcarine cortex thickness AI (t = 2.04, p = .04;
hyperactivity/impulsivity) (Table S20).
Current psychostimulant medication use was
associated with two cortical regional surface area
asymmetries, that is, precuneus (t = −2.25,
p = .025) and transverse temporal gyrus (t = −2.34,
p = .020) (Table S22), and with two thickness asym-
metries, that is, inferior parietal cortex (t = −2.33,
p = .020) and precentral gyrus (t = −2.16, p = .031)
(Table S23). Lifetime psychostimulant medication
use was associated with three cortical surface area
asymmetries (insula (t = −2.03, p = .043), supra-
marginal gyrus (t = −2.08, p = .038), and rostral
anterior cingulate cortex (t = 1.97, p = .049)
(Table S22), and the thickness asymmetry of the
paracentral lobule (t = 2.15, p = .032) (Table S23).
Among the AIs which showed nominally significant
associations with medication use, one had also
shown a nominally significant association with diag-
nosis in all age groups combined, that is, the AI of
paracentral lobule surface area (see above). The
direction of medication effect was positive, that is,
the opposite to the effect of diagnosis on this AI (see
above).
For mood disorder, associations were observed
with six thickness AIs (i.e., entorhinal cortex, pars
triangularis of inferior frontal gyrus, pericalcarine
cortex, precuneus, rostral middle frontal gyrus, and
transverse temporal gyrus), and two surface area AIs
(i.e., inferior temporal gyrus, and rostral anterior
cingulate cortex), of which the association with
rostral middle frontal thickness AI survived multiple
testing correction (FDR < 0.05) (Tables S5 and S26).
Table 2 Linear mixed model results for the cortical surface area AIs






pa db pa db pa db pa db
Banks of superior temporal sulcus .80 −.01 .53 −.05 .81 .01 .48 −.02
Caudal anterior cingulate cortex .75 −.01 .29 −.08 .71 .02 .64 −.02
Caudal middle frontal cortex .41 .04 .55 −.05 .22 .07 .19 .04
Cuneus .16 .07 .92 −.01 .07 −.11 .74 −.01
Entorhinal cortex .95 .003 .42 −.06 .10 −.10 .34 −.03
Frontal pole .05 −.09 .22 .09 .25 −.07 .10 −.05
Fusiform gyrus .17 −.06 .35 .07 .11 −.10 .15 −.05
Inferior parietal cortex .27 .05 .98 −.002 .89 −.01 .44 .03
Inferior temporal gyrus .57 .03 .84 .02 .25 .07 .25 .04
Insula .10 .08 .56 .04 .64 −.03 .28 .04
Isthmus cingulate cortex .95 −.003 .19 −.10 .49 .04 .75 −.01
Lateral occipital cortex .59 −.02 .96 −.004 .05 .12 .48 .02
Lateral orbitofrontal cortex .18 −.06 .54 −.05 .42 −.05 .06 −.06
Lingual gyrus .88 −.01 .14 −.11 .50 .04 .92 −.003
Medial orbitofrontal cortex .01 .13 .27 .08 .72 −.02 .03 .07
Middle temporal gyrus .15 .07 .45 −.06 .89 −.01 .38 .03
Paracentral lobule .03 −.10 .96 −.004 .28 −.06 .03 −.07
Parahippocampal gyrus .37 .04 .25 −.09 .13 −.09 .73 −.01
Pars opercularis of inferior frontal gyrus .88 .01 .19 .10 .58 .03 .34 .03
Pars orbitalis of inferior frontal gyrus .20 .06 .02 .18 .55 .04 .02 .08
Pars triangularis of inferior frontal gyrus .32 .05 .14 .11 .57 −.03 .24 .04
Pericalcarine cortex .30 .05 .13 −.12 1.00 .00 .94 .002
Postcentral gyrus .44 .04 .29 .08 .98 .00 .39 .03
Posterior cingulate cortex .62 −.02 .46 −.06 .84 .01 .59 −.02
Precentral gyrus .85 .01 .09 −.13 .05 −.12 .09 −.06
Precuneus .29 .05 .47 −.06 .65 .03 .46 .02
Rostral anterior cingulate cortex .97 −.002 .98 .002 .36 −.05 .51 −.02
Rostral middle frontal gyrus .10 −.08 .77 −.02 .60 −.03 .11 −.05
Superior frontal gyrus .28 .05 .09 .13 .11 −.09 .55 .02
Superior parietal cortex .09 .08 .33 .07 .68 −.02 .27 .04
Superior temporal gyrus .09 .08 .87 .01 .19 −.08 .62 .02
Supramarginal gyrus .86 .01 .25 −.09 .21 −.07 .24 −.04
Temporal pole .65 .02 .69 .03 .34 −.06 .97 .001
Transverse temporal gyrus .66 −.02 .44 .06 .94 .005 .93 .003
Total average surface area .04 .10 .73 .03 .23 −.07 .54 .02
aUncorrected p-values for diagnosis are indicated, with in bold those that are significant at the uncorrected level (p < .05). None
survived multiple testing correction.
bCohen’s d value for the effect of diagnosis.
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Anxiety Disorder was associated with thickness AIs
of the cuneus and lateral occipital cortex (Table
S26). For ODD, associations were found with the AIs
of medial orbitofrontal thickness (Table S26) and
temporal pole surface area (Table S25). Additionally,
SUD was associated with the thickness AIs of the
cuneus and paracentral lobule (Table S26), and with
surface area AIs of the postcentral gyrus and supra-
marginal gyrus (Table S25). None of these regions
showed a nominally significant effect of diagnosis in
the main analysis of all age groups combined.
Finally, within ADHD individuals, IQ was nomi-
nally associated with the accumbens volume AI
(t = 2.16, p = .031), hippocampus volume AI
(t = −2.06, p = .039) (Table S27), and lateral occip-
ital cortex surface area AI (t = −2.17, p = .030)
(Table S28). Within controls, IQ was associated with
the middle temporal gyrus surface area AI
(t = −2.52, p = .012) (Table S28), rostral anterior
cingulate thickness cortex AI (t = 2.47, p = .014),
and supramarginal gyrus thickness AI (t = −2.55,
p = .011) (Table S29).
Including IQ, handedness, or intracranial volume
as covariates in case–control analysis. We carried
out secondary analyses in which IQ, handedness, or
intracranial volume were included as covariates in
case–control analysis, with or without interaction
terms for these variables with diagnosis (i.e., case–-
control status) (see Methods for the models used).
These extra models identified a small number of
main effects of diagnosis, or interactions with diag-
nosis, that survived multiple testing correction at
FDR < 0.05 within the specific subset of AIs and
ages being analyzed (but would not survive further
correction for multiple testing). However, after win-
sorization of outliers (see Methods), only the diagno-
sis term for globus pallidus volume AI remained







pa db pa db pa db pa db
Banks of superior temporal sulcus .05 −.10 .54 −.05 .64 −.03 .06 −.06
Caudal anterior cingulate cortex .25 .05 .60 −.04 .06 .11 .11 .05
Caudal middle frontal cortex .04 .10 .09 .13 .73 .02 .03 .07
Cuneus .69 .02 .04 −.15 .06 .11 .56 .02
Entorhinal cortex .12 −.08 .79 .02 .65 −.03 .26 −.04
Frontal pole .27 .05 .20 −.10 .19 .08 .34 .03
Fusiform gyrus .56 −.03 .98 .002 .79 .02 .94 −.003
Inferior parietal cortex .96 .00 .59 −.04 .51 .04 .81 .01
Inferior temporal gyrus .24 −.05 .79 .02 .84 −.01 .69 −.01
Insula .05 −.09 .32 −.08 .94 −.004 .05 −.06
Isthmus cingulate cortex .81 −.01 .22 .09 .35 −.06 .91 .00
Lateral occipital cortex .76 .01 .40 −.06 .03 .13 .41 .03
Lateral orbitofrontal cortex .75 −.01 .51 .05 .14 .09 .42 .03
Lingual gyrus .34 −.04 .85 .01 .59 −.03 .29 −.04
Medial orbitofrontal cortex .06 −.09 .31 .08 .04 .12 .97 .001
Middle temporal gyrus .75 −.02 .62 −.04 .01 −.17 .11 −.05
Paracentral lobule .15 −.07 .12 .12 .77 −.02 .53 −.02
Parahippocampal gyrus .07 −.09 .09 −.13 .39 .05 .12 −.05
Pars opercularis of inferior frontal gyrus .80 .01 .39 .07 .89 −.01 .45 .02
Pars orbitalis of inferior frontal gyrus .36 .04 .95 −.004 .37 .05 .30 .03
Pars triangularis of inferior frontal gyrus .67 −.02 .36 .07 .90 −.01 .92 .003
Pericalcarine cortex .92 −.004 .98 −.002 .004 .17 .15 .05
Postcentral gyrus .94 −.004 .92 −.01 .01 −.15 .11 −.05
Posterior cingulate cortex .57 −.03 .47 −.05 .87 −.01 .35 −.03
Precentral gyrus .02 .11 .32 −.08 .17 .08 .05 .06
Precuneus .73 .02 .22 .09 .69 .02 .36 .03
Rostral anterior cingulate cortex .92 −.004 .06 .15 .36 .06 .21 .04
Rostral middle frontal gyrus .68 .02 .78 −.02 .34 −.06 .85 −.01
Superior frontal gyrus .77 .01 .10 .13 .64 .03 .30 .03
Superior parietal cortex .98 −.001 .47 −.06 .85 .01 .77 −.01
Superior temporal gyrus .06 .09 .42 .07 .36 −.06 .28 .04
Supramarginal gyrus .18 −.06 .51 −.05 .93 −.005 .19 −.04
Temporal pole .56 .03 .77 .02 .62 −.03 .77 .01
Transverse temporal gyrus .66 .02 .65 .03 .34 −.06 .98 −.001
Total average thickness .92 −.005 .78 .02 .75 .02 .78 .01
aUncorrected p-values for the effects of diagnosis are indicated, with in bold those that are significant at the uncorrected level
(p < .05). None of the associations with diagnosis survived multiple testing correction.
bCohen’s d value for the effect of diagnosis.
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significant, in the model AI ~ diagnosis + age + sex +
ICV + random (~1|dataset), when analyzed in the
total study sample (p = .005, t = −2.75), or when
analyzed in adults only (p = .0035, t = −2.93). Com-
plete model results from all of these secondary
analyses can be found in supplementary comma-
delimited text files.
Discussion
We conducted the largest study to date of associa-
tions between anatomical brain asymmetries and
ADHD. Linear mixed effects model mega-analyses
were carried out separately in children, adolescents,
and adults, following previous ENIGMA-ADHD
working group studies of bilateral brain differences
that showed contrasting effects in these age groups
(Hoogman et al., 2017, 2019). We also analyzed the
total study sample for age-general effects. All sta-
tistical effects of diagnosis on asymmetries were
very small, with Cohen’s d ranging from −.18 to .18.
Only one of these associations was significant with
a false discovery rate < 0.05 within the specific
subset of AIs and age-defined subjects in which it
was found (globus pallidus asymmetry in adults),
and this effect was not significant in analysis of all
age groups combined, with FDR correction across
all AIs. Therefore, all effects remain tentative, even
in this unprecedented sample size. The small effect
sizes mean that altered brain asymmetry is unli-
kely, in itself, to be a useful biomarker or clinical
predictor of ADHD. In addition, our results suggest
that significant effects reported in prior studies,
based on much smaller samples, may have been
unrealistically large. As noted in the Introduction,
low power not only reduces the chance of detecting
true effects, but also increases the likelihood that
statistically significant results do not reflect true
effects (Munafo & Flint, 2010). There were some
notable associations of diagnosis with cortical
asymmetry that reached nominal significance in
our study. Among these, children with ADHD
showed reduced rightward asymmetry of total
hemispheric surface area and medial orbitofrontal
surface area. In a recent ENIGMA consortium study
of autism spectrum disorder (ASD), medial orbito-
frontal cortex surface area asymmetry was altered
in the same direction, and to a similar extent, as in
the present study (Postema et al., 2019). ADHD and
ASD often co-occur (Leitner, 2014) and are known
to share genetic influences (Ghirardi et al., 2019;
Stergiakouli et al., 2017), such that the two diag-
nostic labels are likely to capture a partly overlap-
ping spectrum of related disorders (Demopoulos,
Hopkins, & Davis, 2013; van der Meer et al., 2012).
Studies that aimed to identify shared brain struc-
tural traits between ADHD and ASD have found
mixed results (Boedhoe et al., 2019; Radonjić et al.,
2019), with perhaps the greatest overlap involving
regions of the ‘social brain’, including orbitofrontal
cortex (Baribeau et al., 2019). However, laterality
has not been specifically studied in this regard, so
that our finding of reduced rightward medial
orbitofrontal cortex surface area in both disorders
may be a new insight into shared neurobiology
between ADHD and ASD. Altered lateralized neu-
rodevelopment may play a causal role in disorder
susceptibility, or else may arise as a correlated trait
due to other underlying susceptibility factors, or
even be a downstream consequence of having the
disorder (Bishop, 2013). Some aspects of brain
asymmetry are partly heritable (Guadalupe et al.,
2016; Kong et al., 2018), so that future gene
mapping studies for brain asymmetry and disorder
susceptibility may help to resolve causal relations
underlying their associations.
One functional imaging study (94 cases, 85 con-
trols) reported lower rightward lateralization in
medial orbitofrontal cortex in ADHD compared to
controls, based on temporal variability during rest-
ing-state (Zou & Yang, 2019). Furthermore, a study
of 218 participants with ADHD and 358 healthy
controls reported that orbitofrontal cortex thickness,
but not surface area, showed a left > right asymme-
try in childhood controls that switched to right > left
asymmetry by late adolescence, while this change
did not occur to the same extent in ADHD (Shaw
et al., 2009). However, in the present study, there
was no effect of diagnosis on thickness asymmetry of
this region in children or adolescents, while in
adults, ADHD was associated with a relatively right-
ward shift of asymmetry compared to controls, that
is, opposite to what might be expected according to
Shaw et al. For other cortical asymmetries too, our
findings in this large-scale study were discrepant
with what might have been expected from previous
reports in smaller samples (see references in the
Introduction). For example, a prior study reported
reversed gray matter volume asymmetry (i.e., left-
ward instead of rightward) of the superior frontal
gyrus in ADHD (Cao et al., 2014), but we saw no
clear evidence of this in the present study.
The most often reported alteration of brain asym-
metry in ADHD has involved the caudate nucleus,
although the direction of the effect has not been
consistent (Castellanos et al., 1996; Dang et al.,
2016; Filipek et al., 1997; Hynd et al., 1993;
Schrimsher et al., 2002; Uhlikova et al., 2007). We
did not find evidence for altered asymmetry of cau-
date nucleus volume in the present study, again
suggesting that prior findings were false positives in
smaller samples. As mentioned above, we found a
tentative association with ADHD for another regional
asymmetry of the basal ganglia, namely of the globus
pallidus, in adults-only. The globus pallidus is
involved in movement and reward processing (Munte
et al., 2017), both of which are involved in the
symptomatology of ADHD. A previous meta-analysis
comprising data from a total of 114 participants with
ADHD (or a related disorder) and 143 control
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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participants, noted a significantly lower average
right putamen and right globus pallidus volumes in
ADHD (Ellison-Wright, Ellison-Wright, & Bullmore,
2008), although asymmetry was not quantified in
that study. Regardless, our finding of lower left-
ward asymmetry seems discrepant with this earlier
report.
We have already remarked on the limited statisti-
cal power of previous studies as a likely explanation
for their findings being discrepant with the current
study. Low sample sizes in relation to subtle effects
can result in poor reproducibility (Button et al.,
2013; Munafo & Flint, 2010). Here, we had 80%
power to detect case–control Cohen’s d effect sizes as
low as roughly .12, or as high as 0.3 in the smallest
subset by age (see Methods). In addition to limited
sample sizes, there are various other possible expla-
nations for discrepancies with previous studies.
Methodological differences in hardware, software,
and data processing pipelines can influence results
(Biberacher et al., 2016), although our focus on
asymmetry through use of the AI is likely to have
reduced the impact of heterogeneity factors that
affect both hemispheres equally. In contrast to some
previous studies mentioned above, we did not con-
sider gyral/sulcal patterns or cortical gray matter
volumes as such. Rather, we studied regional corti-
cal thicknesses and surface areas as distinct mea-
sures, which together drive gray matter volumetric
measures. Since area and thickness have been
shown to vary relatively independently (Panizzon
et al., 2009), separate analyses are advisable,
although cortical thickness measures are particu-
larly prone to effects related to site-, scanner- or
protocol differences (Chung et al., 2017; Fortin et al.,
2018). Likewise, the choice of brain atlas can influ-
ence results, as each atlas has its own properties
that impact brain segmentation (Yaakub et al.,
2020). In addition, the approach we used is based
on hemisphere-specific definitions of regional anat-
omy, because each hemisphere has its own atlas,
based on its own average distribution of features
(Desikan et al., 2006). Correspondence between
hemispheres is then achieved at the regional level,
based on expert neuroanatomical regional segmen-
tation that was adapted to each hemisphere’s dis-
tinct features when constructing the atlas. However,
future studies using higher-resolution atlases, or
vertex-based analysis using hemispheric co-regis-
tration (Kang, Herron, Cate, Yund, & Woods, 2012;
Maingault, Tzourio-Mazoyer, Mazoyer, & Crivello,
2016), may identify restricted regions showing
stronger associations between ADHD and cortical
asymmetry than we report here. Furthermore, for
subcortical volume asymmetries, discrepancies
between the findings of our study and previous
studies could be due to differences in parcellation
methods, which can perform with varying accuracy
(Guadalupe et al., 2014; Pardoe, Pell, Abbott, &
Jackson, 2009; Perlaki et al., 2017).
The conceptualization of laterality can also differ
across studies. In terms of AIs, our cortical results
are largely in line with a previous report based on
measuring gray matter volume asymmetries in 192
participants with ADHD and 508 controls (Douglas
et al., 2018), insofar as no FDR-significant results
were found (five of those datasets were in common
with the present study, see Methods). However, the
authors of that study also calculated the unsigned
magnitudes of the AIs (i.e., absolute degrees of
asymmetry, regardless of directions). They reported
significant differences in absolute asymmetry for
various cortical and subcortical structures (Douglas
et al., 2018). In the present study, we did not
calculate absolute AIs, in order not to compound
multiple testing, and because these measures are
highly non-normal with a floor effect at value zero,
which would violate the assumptions of the modeling
that we applied. It is not clear whether this issue may
have affected the results in the earlier study (Dou-
glas et al., 2018). Future studies may consider the
unsigned magnitude of brain asymmetry indexes
further in ADHD, but it will be necessary to use
statistical methods that can account for non-normal
distributions.
Discrepancies with earlier studies may also be due
to differences in clinical features of the disorder that
arise from case recruitment and diagnosis, for
example with respect to medication use (which has
been suggested to partly normalize brain structural
abnormalities, although the previous ENIGMA stud-
ies of bilateral changes in ADHD did not support
this) (Nakao, Radua, Rubia, & Mataix-Cols, 2011;
Pretus et al., 2017), comorbidities (Reale et al.,
2017), symptom severity, and/or IQ. Some asymme-
tries showed tentative associations with some of
these clinical variables in the present study,
although none of these results survived correction
for multiple testing, apart from mood disorder with
the rostral middle frontal thickness AI. Also, some of
the clinical variables (medication, comorbidity) were
missing for many ADHD individuals in this study.
Regardless, it remains possible that certain subsets
of ADHD might be associated more strongly with
altered brain asymmetry than was apparent in our
large-scale analysis of average changes over many
datasets, comprising many and varied collections of
ADHD individuals and controls.
In general, between-center heterogeneity (in terms
of scanning setup, patient subgroups, demograph-
ics) may result in reduced statistical power to detect
effects that are specific to certain subgroups of
datasets, or to individual datasets, when tested in
mega-analysis over all datasets. For example, har-
monization of scanning protocols might lead to
stronger effects being found, as heterogeneity of this
aspect would be reduced. Here, we used random-
intercept models to adjust for heterogeneity between
datasets. This was a strong correction for cross-
dataset heterogeneity, as it removed mean
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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differences between datasets, although between-
dataset heterogeneity that affected model coefficients
within datasets would not be fully accounted by this
approach. While the random-intercept model cannot
fully rescue power in the case that effects are truly
specific to certain subsets, no single center has been
able to collect such a large ADHD-control sample
alone. Our large sample size yields accurate esti-
mates of effect sizes with respect to the overall
case–control population, as represented across
many research centers. In this way, the findings
from multi-center studies such as ours can be
considered more generalizable than single-center
studies (Costafreda, 2009). In any case, as long as
researchers publish separate papers based on many
single, smaller datasets, collected in particular ways,
the field overall has the same issue of heterogeneity.
Of note, the ENIGMA consortium previously showed
that using the random-intercept approach to
account for dataset heterogeneity is similar to ran-
dom effect meta-analysis across datasets, but prefer-
able because it produces lower standard errors and
Figure 1 Cohen’s d effect sizes of the associations between ADHD diagnosis and AIs of subcortical volumes, cortical surface areas and
cortical thicknesses for (A) children, (B) adolescents, (C) adults, and (D) all age groups combined. Positive values (red) indicate mean shifts
towards greater leftward or reduced rightward asymmetry in ADHD, and negative values (blue) indicate mean shifts towards greater
rightward asymmetry or reduced leftward asymmetry in ADHD.
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narrower confidence intervals than meta-analysis
(Boedhoe et al., 2018).
Although not a longitudinal study, our data
spanned a wide age range from childhood through
to older adulthood, which allowed us to study differ-
ent age groups separately, as the disorder may be
neurobiologically distinct in different age groups
(Alexander & Farrelly, 2018; Hoogman et al., 2019).
The previous ENIGMA study of bilateral cortical
differences in ADHD found children to be most
affected, particularly in frontal, cingulate, and tem-
poral regions, as well as the total hemispheric surface
area, which was lower in ADHD (Hoogman et al.,
2019). In the children-only analysis in our present
study of asymmetries, we also found associations
with diagnosis for some frontal and temporal regions
(including the caudal middle frontal cortex thick-
ness, precentral gyrus thickness, medial orbitofron-
tal cortex surface area, banks of the superior
temporal sulcus thickness), as well as a change in
the asymmetry of total hemispheric surface area,
driven by a greater decrease of area in ADHD on the
right-side than the left-side. These findings offer a
more nuanced description of brain changes in child-
hood ADHD, which may involve altered lateralized
neurodevelopment.
However, considering all brain asymmetry mea-
sures, the effect sizes in the present study were not
stronger in children as compared to adolescents or
adults. Furthermore, bilateral case–control differ-
ences are not necessarily a good guide to case–con-
trol differences in asymmetry, since a difference in
asymmetry can arise, for example, from a simulta-
neous left-sided increase and right-sided decrease in
a brain measure, which can involve no change at all
in the bilateral measure. Hence, we took a screening
approach to the present study, rather than con-
straining our search on prior bilateral findings. It is
also not entirely clear how/whether to statistically
adjust the test for total hemispheric surface asym-
metry, in the context of also testing multiple sub-
regions, and also with respect to study-wide multiple
testing. Therefore, we present all p-values unad-
justed, while also being mindful of the tentative
nature of these findings in the context of our survey
across many brain asymmetry measures. Together
with the corresponding effect size estimates, this
mapping information should be useful for the field.
We did not include handedness, IQ, or brain size
as covariates in our primary analysis, in order to
avoid possible collider bias (Cole et al., 2010), as
there are various plausible causal relations linking
these traits with ADHD, brain asymmetry and other,
possibly underlying factors shared between some or
all of them. For example, having the disorder for
other underlying reasons may lead to altered asym-
metry and brain size, or altered asymmetry and
brain size may contribute to having the disorder. A
priori, altered asymmetry may not be associated with
the disorder, but be associated with brain size,
which can be associated with disorder. In this latter
case, correcting for brain size can induce spurious
associations between asymmetry and disorder. Col-
lider bias is under-appreciated in the field, perhaps
because it is not intuitive. Alternatively, including
brain size as a covariate in case–control analysis
might have reduced the power to detect an associ-
ation of diagnosis with asymmetry. This would occur
if underlying susceptibility factors contribute both to
altered asymmetry and reduced brain size, as part of
the ADHD phenotype. Regardless, our primary inter-
est was to detect associations of diagnosis with
asymmetry regardless of other brain features such
as overall size. We have made available, in supple-
mentary csv files, the results from secondary anal-
yses in which we included handedness, IQ, or
intracranial volume as covariates, with or without
interaction terms with case–control status. As
regards handedness specifically, previous studies
of subcortical and cortical anatomical asymmetry in
over 15,000 subjects from healthy control and pop-
ulation datasets, also performed by the ENIGMA
consortium (Guadalupe et al., 2016; Kong et al.,
2018), found no significant effects of handedness.
Our study was limited to macro-anatomical asym-
metries of cortical gray matter and subcortical vol-
umes. It is possible that altered brain asymmetry in
ADHD will be more apparent in different structural
or functional modalities, or at different scales. For
example, cortical thickness measures can correlate
with the degree of myelination (Natu et al., 2019),
such that quantitative neuroimaging methods that
are sensitive to microstructural tissue content may
reveal further alterations in ADHD. At a larger scale,
asymmetries of white matter tracts (Wu et al., 2020)
may also benefit from the large-scale approach that
we have used here. Asymmetries of functional asym-
metry, particularly linked to attentional tasks, may
also reveal stronger case–control differences than the
structural effects we observed (see Introduction).
Conclusion
We carried out the largest case–control study of
structural brain asymmetry in ADHD. We described
average changes of asymmetry that are small, but
helpful towards a more complete description of brain
anatomical changes in this disorder. Results were
largely discrepant with earlier, inconsistent findings
from smaller-scale studies, which illustrates the
value of taking a large-scale approach to human
clinical neuroscience. The small effects that we
found remain statistically tentative in the context of
multiple testing, even in this unprecedented sample
size. Future longitudinal and genetic studies may
probe causative relations between ADHD and brain
asymmetry, focused on measures defined from this
study, such as total hemispheric surface area asym-
metry, medial orbitofrontal area asymmetry, or
globus pallidus volume asymmetry.
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Key points
 The extent to which brain anatomical asymmetry is altered in ADHD has remained unclear. Previous studies
of brain asymmetry in ADHD were based on small sample sizes, so that findings may have been unreliable.
 We carried out the largest-ever study of brain anatomical asymmetry in ADHD. Average case-control
differences of asymmetry were very small, and the regions implicated were largely discrepant with earlier
findings based on smaller samples.
 This study illustrates the value of a large-scale approach to human clinical neuroscience. The findings provide
an improved description of brain anatomical changes in ADHD.
 Of itself, altered anatomical asymmetry is not likely to be a useful biomarker for ADHD. Future longitudinal
and genetic studies may probe causative relations between ADHD and asymmetry of the total hemispheric
surface area, medial orbitofrontal area, and globus pallidus volume.
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